Pitching Drugs To Physicians: Disclosing Limitations Of Clinical Data May Be Beneficial
Executive Summary
US FDA study finds that sales aids for oncology drugs that disclose a study’s data limitations and clinical uncertainty can lead to more appropriate assessments of the data by physicians but does not affect their overall perceptions of a drug’s benefits.